PE20091392A1 - Composiciones farmaceuticas como agentes antiinflamatorios - Google Patents
Composiciones farmaceuticas como agentes antiinflamatoriosInfo
- Publication number
- PE20091392A1 PE20091392A1 PE2008001774A PE2008001774A PE20091392A1 PE 20091392 A1 PE20091392 A1 PE 20091392A1 PE 2008001774 A PE2008001774 A PE 2008001774A PE 2008001774 A PE2008001774 A PE 2008001774A PE 20091392 A1 PE20091392 A1 PE 20091392A1
- Authority
- PE
- Peru
- Prior art keywords
- cyclopentil
- purin
- pyrrolidin
- ethylamine
- pyridin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
REFERIDO A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: A) UN COMPUESTO SELECCIONADO DE METIL ESTER DE ACIDO ((1S,2R,3S,4R)-4-{6-(2,2-DIFENIL-ETILAMINO)-2-[(S)-3-(3-PIRIDIN-3-IL-UREIDO)-PIRROLIDIN-1-IL]-PURIN-9-IL}-2,3-DIHIDROXI-CICLOPENTIL)-CARBAMICO; METIL ESTER DE ACIDO ((1S, 2R, 3S, 4R)-4-{6-(2,2-DIFENIL-ETILAMINO)-2-[(R)-3-(3-PIRIDIN-3-IL-UREIDO)-PIRROLIDIN-1-IL}-PURIN-9-IL]-2,3-DIHIDROXI-CICLOPENTIL)-CARBAMICO; ((1S,2R,3S,4R)-4-{6-(2,2-DIFENIL-ETILAMINO)-2-[(R)-3-(3-PIRIDIN-3-IL-UREIDO)PIRROLIDIN-1-IL]-PURIN-9-IL}-2,3-DIHIDROXI-CICLOPENTIL)-AMIDA; ENTRE OTROS Y B) UNO O MAS COMPUESTOS SELECCIONADOS DE i) UN CORTICOSTEROIDE, ii) UN ANTAGONISTA DE BETA-2 ADRENOCEPTOR, iii) UN AGENTE ANTIMUSCARINICO, iv) UN ANTAGONISTA DE A2B, v) UNA ANTIHISTAMINA, ENTRE OTROS. TAMBIEN SE REFIERE A UN KIT QUE COMPRENDE UNA COMPOSICION FARMACEUTICA Y UN DISPOSITIVO DE INHALACION. SIENDO UTILES EN EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS U OBSTRUCTIVAS DE LAS VIAS RESPIRATORIAS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07118721 | 2007-10-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20091392A1 true PE20091392A1 (es) | 2009-10-14 |
Family
ID=39185790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2008001774A PE20091392A1 (es) | 2007-10-17 | 2008-10-15 | Composiciones farmaceuticas como agentes antiinflamatorios |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20090181934A1 (es) |
| EP (1) | EP2211865A2 (es) |
| JP (1) | JP2011500630A (es) |
| KR (1) | KR20100075925A (es) |
| CN (1) | CN101827596A (es) |
| AR (1) | AR068879A1 (es) |
| AU (1) | AU2008313788A1 (es) |
| BR (1) | BRPI0818005A2 (es) |
| CA (1) | CA2702942A1 (es) |
| CL (1) | CL2008003057A1 (es) |
| CR (1) | CR11341A (es) |
| CU (1) | CU20100065A7 (es) |
| EA (1) | EA201000617A1 (es) |
| IL (1) | IL204723A0 (es) |
| MA (1) | MA31796B1 (es) |
| MX (1) | MX2010004252A (es) |
| PE (1) | PE20091392A1 (es) |
| TN (1) | TN2010000168A1 (es) |
| TW (1) | TW200927129A (es) |
| WO (1) | WO2009050198A2 (es) |
| ZA (1) | ZA201002336B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GT200500281A (es) * | 2004-10-22 | 2006-04-24 | Novartis Ag | Compuestos organicos. |
| GB0500785D0 (en) | 2005-01-14 | 2005-02-23 | Novartis Ag | Organic compounds |
| AR060607A1 (es) * | 2006-04-21 | 2008-07-02 | Novartis Ag | Derivados de purina,composiciones farmaceuticas que los contienen, metodo de preparacion y usos en enfermedades obstructivas o inflamatorias de las vias respiratorias. |
| GB0607950D0 (en) * | 2006-04-21 | 2006-05-31 | Novartis Ag | Organic compounds |
| GB0607945D0 (en) * | 2006-04-21 | 2006-05-31 | Novartis Ag | Organic compounds |
| GB0607953D0 (en) * | 2006-04-21 | 2006-05-31 | Novartis Ag | Organic compounds |
| GB0607948D0 (en) * | 2006-04-21 | 2006-05-31 | Novartis Ag | Organic compounds |
| GB0607944D0 (en) * | 2006-04-21 | 2006-05-31 | Novartis Ag | Organic compounds |
| EP1889846A1 (en) | 2006-07-13 | 2008-02-20 | Novartis AG | Purine derivatives as A2a agonists |
| EP1903044A1 (en) * | 2006-09-14 | 2008-03-26 | Novartis AG | Adenosine Derivatives as A2A Receptor Agonists |
| RU2009121819A (ru) * | 2006-11-10 | 2010-12-20 | Новартис АГ (CH) | Производные моноацетата циклопентендиола |
| AU2008313789A1 (en) * | 2007-10-17 | 2009-04-23 | Novartis Ag | Purine derivatives as adenosine AL receptor ligands |
| WO2013156614A1 (en) | 2012-04-20 | 2013-10-24 | Ucb Pharma S.A. | Methods for treating parkinson's disease |
| CA3126735A1 (en) | 2019-01-11 | 2020-07-16 | Omeros Corporation | Methods and compositions for treating cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GT200500281A (es) * | 2004-10-22 | 2006-04-24 | Novartis Ag | Compuestos organicos. |
| GB0607950D0 (en) * | 2006-04-21 | 2006-05-31 | Novartis Ag | Organic compounds |
| GB0607945D0 (en) * | 2006-04-21 | 2006-05-31 | Novartis Ag | Organic compounds |
| GB0607953D0 (en) * | 2006-04-21 | 2006-05-31 | Novartis Ag | Organic compounds |
| AR060607A1 (es) * | 2006-04-21 | 2008-07-02 | Novartis Ag | Derivados de purina,composiciones farmaceuticas que los contienen, metodo de preparacion y usos en enfermedades obstructivas o inflamatorias de las vias respiratorias. |
-
2008
- 2008-10-08 US US12/247,764 patent/US20090181934A1/en not_active Abandoned
- 2008-10-15 WO PCT/EP2008/063869 patent/WO2009050198A2/en active Application Filing
- 2008-10-15 AU AU2008313788A patent/AU2008313788A1/en not_active Abandoned
- 2008-10-15 CN CN200880112188A patent/CN101827596A/zh active Pending
- 2008-10-15 CA CA2702942A patent/CA2702942A1/en not_active Abandoned
- 2008-10-15 KR KR1020107008300A patent/KR20100075925A/ko not_active Application Discontinuation
- 2008-10-15 JP JP2010529369A patent/JP2011500630A/ja active Pending
- 2008-10-15 EA EA201000617A patent/EA201000617A1/ru unknown
- 2008-10-15 PE PE2008001774A patent/PE20091392A1/es not_active Application Discontinuation
- 2008-10-15 MX MX2010004252A patent/MX2010004252A/es not_active Application Discontinuation
- 2008-10-15 AR ARP080104494A patent/AR068879A1/es not_active Application Discontinuation
- 2008-10-15 EP EP08838649A patent/EP2211865A2/en not_active Withdrawn
- 2008-10-15 BR BRPI0818005 patent/BRPI0818005A2/pt not_active IP Right Cessation
- 2008-10-16 CL CL2008003057A patent/CL2008003057A1/es unknown
- 2008-10-16 TW TW097139728A patent/TW200927129A/zh unknown
-
2010
- 2010-03-25 IL IL204723A patent/IL204723A0/en unknown
- 2010-03-26 CR CR11341A patent/CR11341A/es not_active Application Discontinuation
- 2010-04-01 ZA ZA2010/02336A patent/ZA201002336B/en unknown
- 2010-04-14 CU CU20100065A patent/CU20100065A7/es unknown
- 2010-04-16 TN TN2010000168A patent/TN2010000168A1/fr unknown
- 2010-04-30 MA MA32802A patent/MA31796B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008313788A1 (en) | 2009-04-23 |
| CN101827596A (zh) | 2010-09-08 |
| MX2010004252A (es) | 2010-04-30 |
| WO2009050198A3 (en) | 2009-09-11 |
| CA2702942A1 (en) | 2009-04-23 |
| BRPI0818005A2 (pt) | 2015-04-14 |
| AR068879A1 (es) | 2009-12-09 |
| WO2009050198A2 (en) | 2009-04-23 |
| KR20100075925A (ko) | 2010-07-05 |
| CU20100065A7 (es) | 2011-10-05 |
| TW200927129A (en) | 2009-07-01 |
| US20090181934A1 (en) | 2009-07-16 |
| MA31796B1 (fr) | 2010-10-01 |
| EA201000617A1 (ru) | 2010-10-29 |
| ZA201002336B (en) | 2011-04-28 |
| EP2211865A2 (en) | 2010-08-04 |
| JP2011500630A (ja) | 2011-01-06 |
| IL204723A0 (en) | 2010-11-30 |
| CR11341A (es) | 2010-05-06 |
| TN2010000168A1 (en) | 2011-11-11 |
| CL2008003057A1 (es) | 2009-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20091392A1 (es) | Composiciones farmaceuticas como agentes antiinflamatorios | |
| PE20071250A1 (es) | Formulaciones farmaceuticas que comprenden pleconaril | |
| EA200900155A1 (ru) | Модуляторы фармакокинетических свойств лекарственных средств | |
| AR063118A1 (es) | Derivados de sulfonamida-piperidina composiciones farmaceuticas que los contienen y usos en enfermedades y trastornos inflamatorios alergicos y respiratorios | |
| CL2008003096A1 (es) | Compuestos derivados de piperidino-dihidrotienopirimidinas; inhibidores pde4; composicion farmaceutica que los comprende; y uso en el tratamiento de trastornos o enfermedades de las vias respiratorias o gastrointestinales, como tambien enfermedades inflamatorias de las articulaciones u ojos, entre otras. | |
| NO20092723L (no) | Indazolylester og amidderivater for behandling av gluccocorticoid reseptormedierte sykdommer | |
| NO20084853L (no) | Forbindelser som er agonister av muscarinreseptorer og som kan vaere effektive i behandling av smerte, Alzheimers sykdom og/eller schizofreni | |
| PE20121396A1 (es) | Composicion farmaceutica que comprende bromuro de glicopirronio y formoterol | |
| EA200971081A1 (ru) | Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7 | |
| SV2005002099A (es) | " nuevos compuestos " ref. pc 32096a | |
| AR071609A1 (es) | Inhibidores ciclicos de 11(beta) -hidroxiesteroide deshidrogenasa 1 | |
| ECSP088239A (es) | Composición de liberación de fármaco sostenida | |
| MX2010003346A (es) | Piperazino-dihidrotienopirimidinas sustituidas en heterociclo. | |
| CL2009000662A1 (es) | Compuestos derivados de 1,2,4-triazol trisustituidos, moduladores del receptor de acetilcolina nicotinicos; composicion farmaceutica; su proceso de preparacion; y uso para la prevencion o el tratamiento de trastornos psicoticos, trastornos o enfermedades de daño intelectual, o enfermedades o trastornos inflamatorios. | |
| ECSP099177A (es) | Derivados de quinazolinona e isoquinolinona | |
| CR10621A (es) | Derivados de adenosina como agonistas del receptor a2a | |
| BRPI0518993A2 (pt) | composto ou um sal, solvato ou Éster farmaceuticamente aceitÁvel do mesmo, composiÇço farmacÊutica, e, uso de um composto | |
| PE20081374A1 (es) | Combinacion que comprende un agente antipsicotico y (2s)-(4e)-n-metil-5-[3-(5-isopropoxipiridin)il]-4-penten-2-amina | |
| PE20080331A1 (es) | Composiciones farmaceuticas estabilizadas que comprenden fesoterodina | |
| EA201100358A1 (ru) | Дабигатран для чрескожной хирургической катетеризации сердца | |
| BRPI0509074A (pt) | composições farmacêuticas compreendendo agonistas do receptor da tiróide | |
| ECSP088967A (es) | Agonistas del receptor muscarínico que son efectivos en el tratamiento del dolor, la enfermedad de alzheimer y la esquizofrenia | |
| PE20071231A1 (es) | Formulaciones farmaceuticas de pleconaril | |
| CL2007002899A1 (es) | Compuestos derivados de azaciclilaminas n-sustituidas, inhibidores del receptor de histamina 3; proceso de preparacion; composicion farmaceutica que comprende los compuestos, y usopara el tratamiento de trastornos cognitivos, esquizofre nia y enfermedad de alzheimer entre otros. | |
| WO2008012338A3 (en) | Pharmaceutical formulations comprising azelastine and a corticosteroid for the treatment of inflammatory or allergic conditions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |